Eliana Clark - Jul 1, 2024 Form 4 Insider Report for Intellia Therapeutics, Inc. (NTLA)

Role
EVP, Chief Technical Officer
Signature
/s/ James Basta, attorney-in-fact
Stock symbol
NTLA
Transactions as of
Jul 1, 2024
Transactions value $
-$9,287
Form type
4
Date filed
7/3/2024, 01:15 PM
Previous filing
Mar 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTLA Common Stock Sale -$9.29K -405 -0.56% $22.93 71.5K Jul 1, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of 405 shares that were acquired under the Intellia Therapeutics, Inc. 2016 Employee Stock Purchase Plan on June 28, 2024.